Rewiring pharma logistics

Singapore freight forwarders – Star Concord
08-Jun-2026

  • Pharma airfreight is shifting from scale-driven logistics to highly specialised, knowledge-led operations, where carriers must align closely with pharmaceutical manufacturers, regulators and technology partners as healthcare innovation accelerates.
  • The sector is moving towards integrated ecosystems that link industry players with academic institutions and shared data platforms, improving evidence-based decision-making and strengthening supply chain resilience through common standards and analytics.
  • Compliance is emerging as a major efficiency lever, with digital platforms reducing repetitive audits and fragmented reporting, enabling faster onboarding, lower operational friction and more scalable assurance across global pharma logistics networks.

 

Pharma logistics is being reshaped by the pace of clinical innovation and the increasing precision required in patient-centric medicine. Cargo networks that once optimised for scale are now being pulled towards specialisation, where compliance, temperature integrity, and data visibility sit on equal footing with speed.

“Healthcare has moved on, the world has moved on,” Frank Van Gelder, Secretary General of Pharma.Aero, said, speaking at the Neutral Air Partner’s conference in Marrakech, Morocco. “This shift means that large pharmaceutical companies will continue to compete and evolve, but increasingly the industry needs specialists, top-tier partners who can speak the same language as pharma itself.

For carriers and logistics partners, this shift is less about incremental improvement and more about re-engineering operating models around knowledge intensity. The sector is drifting away from generic handling capabilities towards tightly integrated ecosystems where pharmaceutical manufacturers, airlines and technology providers share operational language and risk frameworks. That convergence is already forcing a recalibration of how value is created across the chain.

“Pharma.Aero hosts around 25 international pharmaceutical companies in leading roles within the association, working hand in hand with logistics service providers, airlines, freight forwarders, trucking companies and technology partners,” Van Gelder continued. “If you are expanding into pharma, our role is to support that journey by building the knowledge base and enabling structured growth of pharma capabilities and protocols.

When an industry challenge emerges, Pharma.Aero works to develop a dedicated project around it, with core focus areas spanning supply chain integration, quality and compliance management, and elevated operational standards. Work also extends into digital transformation, regulatory affairs, and pharmaceutical product distribution, alongside education on advanced therapies such as cell and gene therapy, radioligand therapies and mRNA vaccines, including their specific freight requirements.

“We now have around 100 members, with roughly a quarter directly in pharma, alongside freight forwarders and other logistics stakeholders. We also work closely with industry experts,” Van Gelder expressed. “We connected with universities and major institutions globally. Everything we do is grounded in continuous, evidence-based research and analytics. Nothing is purely commercial; the foundation is knowledge, data, research, and innovation.”

Unlocking efficiency

Compliance is becoming the defining cost and efficiency driver in pharmaceutical logistics. The traditional model, repeated audits, duplicated documentation, and fragmented verification, is being challenged by platform-based approaches that consolidate reporting and standardise visibility across stakeholders. In airfreight terms, this reduces friction not only at the point of shipment but across entire compliance cycles.

The strategic value lies in compressing repetition. When audit intelligence is centralised and reusable, the industry moves away from cyclical inefficiency towards continuous assurance. That shift is not cosmetic; it directly impacts cost-to-serve, speed of onboarding for new partners, and the scalability of compliance across global networks.

“What we are really building is an inversion of the field. Everything moves into a single platform: pre-audits, audit records, checklists, supplier assessments, readiness checks. Today, everyone is effectively rebuilding the same data sets in parallel. That is the inefficiency,” Stefan Hollands, CEO of 4Viso, explained. “For those entering pharma, or building capability in the sector, this also becomes a structured on-ramp. You can access validated frameworks and digital resources that allow faster alignment with pharma compliance requirements.”

 

The post Rewiring pharma logistics appeared first on Air Cargo Week.

Go to Source
Author: Edward Hardy

cURL error: Could not resolve host: bonusra.com